Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients.

Dong XD, Carr BI.

Med Oncol. 2011 Dec;28 Suppl 1:S286-90. doi: 10.1007/s12032-010-9750-6. Epub 2010 Nov 24.

PMID:
21107755
2.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
3.

Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.

Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S.

Int J Oncol. 2002 Aug;21(2):427-32. Review.

PMID:
12118341
4.

Liver transplantation for metastatic neuroendocrine tumors.

Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GF, Flemming P, Ringe B, Pichlmayr R.

Ann Surg. 1997 Apr;225(4):347-54. Review.

5.

Treatment options for unresectable neuroendocrine liver metastases.

John BJ, Davidson BR.

Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):357-69. doi: 10.1586/egh.11.60. Review.

PMID:
22646257
6.

Interventional treatment of gastrointestinal neuroendocrine tumours.

Ahlman H, Wängberg B, Jansson S, Friman S, Olausson M, Tylén U, Nilsson O.

Digestion. 2000;62 Suppl 1:59-68. Review.

PMID:
10940689
7.

Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.

Ruszniewski P, O'Toole D.

Neuroendocrinology. 2004;80 Suppl 1:74-8. Review.

PMID:
15477722
8.

Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.

Yang TX, Chua TC, Morris DL.

Surg Oncol. 2012 Dec;21(4):299-308. doi: 10.1016/j.suronc.2012.07.001. Epub 2012 Jul 28. Review.

PMID:
22846894
9.

Liver transplantation for unresectable neuroendocrine tumor liver metastases.

Rossi RE, Burroughs AK, Caplin ME.

Ann Surg Oncol. 2014 Jul;21(7):2398-405. doi: 10.1245/s10434-014-3523-y. Epub 2014 Feb 22. Review.

PMID:
24562931
10.

Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.

Kennedy A, Bester L, Salem R, Sharma RA, Parks RW, Ruszniewski P; NET-Liver-Metastases Consensus Conference.

HPB (Oxford). 2015 Jan;17(1):29-37. doi: 10.1111/hpb.12326. Epub 2014 Sep 4. Review.

11.

Hepatic arterial embolization in patients with neuroendocrine tumors.

Del Prete M, Fiore F, Modica R, Marotta V, Marciello F, Ramundo V, Di Sarno A, Carratù A, di Roseto Cde L, Tafuto S, Tatangelo F, Baldelli R, Colao A, Faggiano A; Multidisciplinary Group for NeuroEndocrine Tumors of Naples.

J Exp Clin Cancer Res. 2014 May 19;33:43. doi: 10.1186/1756-9966-33-43. Review.

12.

Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.

Capurso G, Rinzivillo M, Bettini R, Boninsegna L, Delle Fave G, Falconi M.

Br J Surg. 2012 Nov;99(11):1480-6. doi: 10.1002/bjs.8842. Epub 2012 Sep 13. Review.

PMID:
22972490
13.

Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.

Wang SC, Fidelman N, Nakakura EK.

Semin Oncol. 2013 Feb;40(1):69-74. doi: 10.1053/j.seminoncol.2012.11.007. Review.

PMID:
23391114
14.

Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.

Zappa M, Abdel-Rehim M, Hentic O, Vullierme MP, Ruszniewski P, Vilgrain V.

Target Oncol. 2012 Jun;7(2):107-16. doi: 10.1007/s11523-012-0219-8. Epub 2012 May 22. Review.

PMID:
22707276
15.

Management of patients with hepatic metastases from neuroendocrine tumors.

Clift AK, Frilling A.

Ann Saudi Med. 2014 Jul-Aug;34(4):279-90. doi: 10.5144/0256-4947.2014.279. Review.

16.

Therapeutic strategies for neuroendocrine liver metastases.

Frilling A, Clift AK.

Cancer. 2015 Apr 15;121(8):1172-86. doi: 10.1002/cncr.28760. Epub 2014 Oct 1. Review.

17.

The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.

Grozinsky-Glasberg S, Bloom AI, Lev-Cohain N, Klimov A, Besiso H, Gross DJ.

Eur J Endocrinol. 2017 Apr;176(4):461-468. doi: 10.1530/EJE-16-0960. Epub 2017 Jan 18. Review.

18.

Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.

Alagusundaramoorthy SS, Gedaly R.

World J Gastroenterol. 2014 Oct 21;20(39):14348-58. doi: 10.3748/wjg.v20.i39.14348. Review.

19.

Update on the management of neuroendocrine hepatic metastases.

Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC.

J Vasc Interv Radiol. 2006 Aug;17(8):1235-49; quiz 1250. Review.

PMID:
16923972
20.

Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.

Blonski WC, Reddy KR, Shaked A, Siegelman E, Metz DC.

World J Gastroenterol. 2005 Dec 28;11(48):7676-83. Review.

Supplemental Content

Support Center